For pharmacists wondering whether bismuth quadruple therapy still reigns as the gold standard, the wait is over—the latest recommendations are here.
Tracy Mahvan, PharmD, MBA, BCGP
Advertisement
Articles by Tracy Mahvan, PharmD, MBA, BCGP
An increase in the use of GLP-1 agonists for weight loss is affecting patients with diabetes who rely on these medications.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tiratricol, First Treatment for MCT8 Deficiency
2
Intensive Chemotherapy in Combination With Quizartinib Versus Midostaurin for FLT3-ITD Mutated Acute Myeloid Leukemia: A Multicenter Cohort Study
3
Retatrutide Cuts Weight Up to 18.8% in Adults With T2D, Obesity
4
September 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
5